FDA Inspection 1167728 — Cooper Institute For Reproductive Hormonal Disorders, P.C.
The FDA completed an inspection of Cooper Institute For Reproductive Hormonal Disorders, P.C. on Apr 1, 2022 in Mount Laurel, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 1, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Mount Laurel, NJ (United States)